mRNA Vaccine - The New Way

Biotechnology
, , , ,
1

Vaccines help body in fighting against diseases caused by foreign agents (bacteria, viruses or other pathogens). They help body for such fight by preparing it with the injection of harmless part of bacteria or virus against which that vaccine will work as and when required. This has been the traditional approach of vaccine manufacture to use the part of bacteria or virus. Now-a-days, this approach is being vanishing and replaced with one of the modern systems, that is, the usage of mRNA in vaccine manufacture, and the vaccine be called as ‘mRNA Vaccine’.

mRNA: also referred as messenger RNA, is a type of RNA (RNA= a nucleic acid which plays key role in protein synthesis and gene expression).

Vaccine: form of weakened, killed or disintegrated microorganisms, injected to the body to fight against diseases.

Combining both these aspects, mRNA vaccine is one of the modern approaches, which is using part of genetic material of bacteria or virus in making a vaccine, and not the part of life-form/ body of bacteria or virus. By this way, the adverse impacts of using traditional vaccines can be alleviated.

By taking an example of mRNA vaccine, it can be better understood its way of functioning, and one such common case is during the COVID-19 pandemic. mRNA vaccines being made that time were able to be injected in the human body’s cells, where this vaccine helped the body cells to generate the proteins that generally found on the surface of virus SARS-CoV-2 which causes COVID-19. These proteins so produced by body cells help body system in developing immune response against the above-mentioned virus causing COVID-19.

Is there any other mRNA Vaccine available in market worldwide or in the pipeline? Also, we can have a discussion on the pros and cons of mRNA vaccines.

References:

https://medlineplus.gov/genetics/understanding/therapy/mrnavaccines/

https://www.genome.gov/about-genomics/fact-sheets/Understanding-COVID-19-mRNA-Vaccines

MBH/AB

14 Likes
Something Basic From Microbiology Lab.- REPLICA PLATING - Types & Applications
2

This is a very informative overview of mRNA vaccines. It is exciting to see how this technology has moved beyond COVID-19 and is now being explored for many other diseases. Faster development and easier redesign make it a powerful tool in future outbreaks.

1 Like
3

Very useful information

1 Like
4

mRNA vaccines is a novel technology and can be used for rapid scaleability and disease prevention. Main issue which needs to be addressed is the specific storage facilities requirements and long term safety concerns.

1 Like
5

Informative.

1 Like
6

After the success of mRNA vaccines in treating COVID-19, there are several mRNA vaccines under trial. It includes mRNA vaccine for respiratory syncytial virus (RSV) and influenza.

2 Likes
7

Very informative post as we all know that mRNA has always been a hero when it comes to Vaccinations. In COVID times too it played a major back bone role in successful development of COVISHEILD vaccines. Vaccines for influenza, zika and rabies are under research and it has been claimed by many researchers that mRNA can be useful again.

1 Like
8

Many more are in the pipeline like vaccines for Respiratory Syncytial Virus (RSV), seasonal influenza, Cytomegalovirus (CMV) and others.

1 Like
9

mRNA vaccine is a great discovery for the field of vaccination.

1 Like
10

This is a very informative post on how mRNA vaccines are reshaping the world of immunization. The shift from conventional vaccines to genetic-based platforms marks a major leap in medical science, especially for diseases requiring rapid vaccine development. Beyond COVID-19, mRNA technology is now being explored for influenza, RSV, HIV, and even certain cancers, showing promising potential for more targeted and adaptable vaccines in the future.

1 Like
11

Excellent description of how mRNA vaccines are revolutionising immunology today! :dna::syringe: They teach our cells to produce innocuous proteins rather than whole pathogens, which results in powerful, targeted immunity with fewer risks. mRNA platforms are currently being tested for vaccines against cancer, RSV, flu, and HIV. :globe_showing_europe_africa::microscope: Which impending mRNA discovery—personalized cancer treatment or infectious disease prevention—do you find most exciting? Let’s go exploring! :speech_balloon::sparkles:

1 Like
12

Very helpful information. mRNA vaccines show a wide range of applications and are a rapidly growing technology. Despite being highly effective for COVID-19, they still have some limitations, such as instability, degradation, storage and transportation challenges. If these challenges are addressed, mRNA vaccines will have a promising future.

1 Like
13

mRNA vaccines represent a major evolution in biomedical science. Instead of relying on weakened pathogens, they use a precise genetic code to teach our immune system how to respond. The quick development timelines and flexibility of this platform open the door to vaccines for cancer, genetic disorders, and rapidly mutating viruses.
A true step forward in personalized and preventive medicine.

1 Like
14

mRNA vaccines are also providing assistance in immunotherapy for cancer treatment, along with being a promising prevention tool for infectious diseases

15

mRNA vaccines are moving beyond COVID, and they could become a major part of routine immunization in the near future. The pros of such vaccines are clear, rapid design, adaptability to new pathogens, and no need to handle live virus. Apart from COVID‑19, several other mRNA vaccines are already available or in late‑stage development. For example, Moderna is advancing mRNA‑1010 for influenza.

1 Like
16

Informative

1 Like
17

mRNA technology is a promising tool for future vaccines and treatments.

1 Like
18

Beyond COVID-19, mRNA vaccines from Moderna and Pfizer-BioNTech are approved or in late-stage trials for influenza, RSV, CMV, cancer, and Zika, with many more in the pipeline worldwide.

Pros include rapid development, high specificity, and no live pathogen use; cons include cold-chain storage needs, higher costs, and limited long-term real-world data compared to traditional vaccines.

1 Like